This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Key figures and dates of the Impact of Brexit for Pharmaceuticals
Published on: Nov 28th, 2019
The current trading dynamic between the UK and EU, in the pharmaceutical sector, represents one of most integrated relationships of all the industry sectors. Not only in terms of product trade, but also in terms of R&D, legislative and regulatory networks, which has been developed for over 40 years. However, the Brexit now appears as game-changer in this relationship, and its impact might be substantially high for pharmaceutical companies which are not prepared on time.
Here’s a snapshot of some of the statistics reflecting the current dynamic and the key dates for Brexit preparation:
Click here to view the infographic in full screen
Questions? Get the answer by our expert team
No two product developments are the same, talk to our experts about your development challenges and we will provide your actional recommendations.